60 Degrees Pharmaceuticals, Inc.
SXTP
$1.61
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -48.77% | -40.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -48.77% | -40.14% | |||
| Cost of Revenue | -51.66% | -43.63% | |||
| Gross Profit | 53.72% | 45.88% | |||
| SG&A Expenses | 28.20% | -2.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.05% | -21.74% | |||
| Operating Income | -9.26% | 17.55% | |||
| Income Before Tax | -45.06% | 37.81% | |||
| Income Tax Expenses | -- | -700.00% | |||
| Earnings from Continuing Operations | -45.24% | 37.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 80.00% | -28.57% | |||
| Net Income | -45.22% | 37.89% | |||
| EBIT | -9.26% | 17.55% | |||
| EBITDA | -9.26% | 17.76% | |||
| EPS Basic | 12.66% | 44.77% | |||
| Normalized Basic EPS | 10.39% | 46.41% | |||
| EPS Diluted | 12.66% | 44.77% | |||
| Normalized Diluted EPS | 10.39% | 46.41% | |||
| Average Basic Shares Outstanding | 61.85% | 16.04% | |||
| Average Diluted Shares Outstanding | 61.85% | 16.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||